
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Isomaltooligosaccharides (IMO) are prebiotic oligosaccharides that selectively stimulate the growth of beneficial gut bacteria, particularly Bifidobacterium and Lactobacillus species. They resist small intestine digestion and undergo fermentation in the colon, producing short-chain fatty acids that enhance gut barrier function.

Reported Benefits (Provisional)
Origin & History

Isomaltooligosaccharides (IMOs) are short-chain carbohydrates derived from starch. They are commonly found in fermented foods and used as a low-calorie sweetener.
Research Narrative (Provisional)
Research shows IMOs can positively influence gut microbiota and improve digestive health. Some studies also suggest benefits in blood sugar regulation.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Low in calories. - High in dietary fiber. - Contains prebiotic properties.
Reported Mechanism (Provisional)
Isomaltooligosaccharides resist hydrolysis by human digestive enzymes due to their α-1,6-glycosidic linkages, allowing them to reach the colon intact. Colonic bacteria, particularly Bifidobacterium and Lactobacillus species, ferment IMO using specific glycosidases, producing short-chain fatty acids (acetate, propionate, butyrate). These metabolites lower colonic pH, inhibit pathogenic bacteria growth, and strengthen intestinal epithelial tight junctions through histone deacetylase inhibition.
Clinical Narrative (Provisional)
Human studies with 5-20g daily IMO supplementation show increased fecal Bifidobacterium counts by 10-100 fold within 2-4 weeks. A randomized controlled trial of 40 constipated adults found 15g daily IMO increased bowel movement frequency from 3.2 to 5.1 per week after 4 weeks. Limited clinical data exists compared to other prebiotics, with most studies being small-scale (20-60 participants) and short-term (2-8 weeks). Evidence for immune and metabolic benefits remains preliminary and requires larger trials.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







